On Wednesday at 11:54 AM (Bangkok time), the share price of Bangkok Chain Hospital Public Company Limited (SET: BCH) grew by 1.50% or THB 0.20 to THB 13.50, with a trading value of THB 42.31 million.
Krungsri Securities (KSS) perceived a slightly positive view from the meeting with executives at BCH, citing:
1) Revenue growth in 2025 is expected to trend better year-on-year and quarter-on-quarter than previously estimated;
2) Net profit in 2Q25 is expected to rise in line with revenue, supported by additional positive factors that offset seasonal weakness;
3) Full-year net profit for 2025 is projected to climb 24% year-on-year, making BCH one of the top-performing hospital stocks under the analyst’s coverage.
As a result, KSS gives a ‘Buy’ rating for BCH and names the stock, along with BDMS, as its top picks in the sector.
In addition, ASL Securities expects BCH’s 2Q25 profit to show robust year-on-year growth, despite low-season impacts from numerous holidays, following the end of Ramadan. Further support comes from an increase in COVID-19 cases, heavier rainfall, and higher MOU revenue from cardiovascular services compared to 1Q25.
Looking into the second half of the year, further year-on-year growth momentum is anticipated, fueled by both Thai and international patients. Growth will also be supported by new medical centers, rebranding activities, and increased hospital accreditation within the group.
ASL maintains its full-year forecasts for 2025 revenue and net profit at 12.85 billion baht (+9.0%) and 1.41 billion baht (+10.2%), respectively. BCH’s 1Q25 figures already accounted for 22.7% of the full-year projections of the analyst.
Following these developments, the stock is rated ‘Buy’ with a target price set at 21.70 baht per share.
